Final Report of the Safety Assessment for PEG-75 Lanolin,PEG-20 Lanolin,PEG-27 Lanolin,PEG-30 Lanolin,PEG-40 Lanolin,PEG-50 Lanolin,PEG-60 Lanolin,and PEG-85 Lanolin
Free accessResearch articleFirst published online July, 1982
Final Report of the Safety Assessment for PEG-75 Lanolin,PEG-20 Lanolin,PEG-27 Lanolin,PEG-30 Lanolin,PEG-40 Lanolin,PEG-50 Lanolin,PEG-60 Lanolin,and PEG-85 Lanolin
PEG Lanolins are the polyethylene glycol ethers of whole lanolin. They are widely used in cosmetics as auxiliary oil/water emulsifiers at concentrations of up to 25%.
PEG Lanolins were found to be nontoxic in acute oral, dermal, and inhalation studies at varying concentrations. They caused little or no eye irritation in rabbits at concentrations of 50-100%. PEG Lanolins at 10-100% caused mild or negligible skin irritation and were reported to be nonsensitizing in guinea pigs. PEG Lanolins were reported to be nonirritating and nonsensitizing in patients at concentrations from 10-60%.
On the basis of the available information, it is concluded that the PEG-75 Lanolin Group is safe as presently used in cosmetic products.
References
1.
COSMETIC INGREDIENT REVIEW (CIR). (1979). Safety Assessment for Acetylated Lanolin Alcohol and Related Ingredients. Final Report. Washington, DC: Cosmetic Ingredient Review.
Schlossman, M.L. and McCarthy, J.P.(May, 1977). Lanolin and its derivatives. Symposium: “Fats in Cosmetics” AOCS meeting, New York.
5.
COSMETIC, TOILETRY and FRAGRANCE ASSOCIATION (CTFA). (1979). Submission of data from CTFA for PEG-75 Lanolin and related compounds. CTFA Cosmetic Ingredient Chemical Descriptions.
6.
Spilker, C. and Richey, T.(1973). Analytical procedures for Lanolin and Lanolin derivatives. Cosmet. Perfum.88(9), 43–8.
7.
BIO-TOXICOLOGY LABORATORIES (BTL). (July, 1975). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-27 Lanolin. Appendix 5. Acute Oral Toxicity.
8.
ICI AMERICA. (April, 1976). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-20 Lanolin. Appendix 6. Acute Oral Toxicity.
9.
ICI AMERICA. (January, 1976). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-50 Lanolin. Appendix 6. Acute Oral Toxicity.
10.
BTL. (October, 1975). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-40 Lanolin. Appendix 3. Acute Oral Toxicity.
11.
BTL. (November, 1976). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-85 Lanolin. Appendix 5. Acute Oral Toxicity.
12.
BTL. (June, 1970). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 3. Acute Oral Toxicity and Primary Skin Irritation.
13.
FOOD and DRUG RESEARCH LABORATORIES (FDRL). (December, 1974). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 1. Acute Oral Toxicity.
14.
LEBERCO LABORATORIES. (September, 1973). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 2. Acute Oral Toxicity.
15.
HILLTOP RESEARCH. (June, 1971). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 5. Acute Oral Toxicity.
16.
WESTBROOK LANOLIN LABORATORIES. (May, 1973). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Supplement. Acute Oral Toxicity.
17.
HILLTOP RESEARCH. (June, 1971). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 5. Acute Dermal Toxicity.
18.
BTL. (July, 1975). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-27 Lanolin. Appendix 5. Acute Dermal Toxicity and Inhalation.
19.
ROSNER-HIXSON LABORATORIES. (February, 1965). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 4. Subchronic Dermal Toxicity.
20.
ICI AMERICA. (April, 1976). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-20 Lanolin. Appendix 6. Eye Irritation.
21.
BTL. (July, 1975). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-27 Lanolin. Appendix 5. Eye Irritation.
22.
HUNTINGDON RESEARCH CENTER. (February, 1973). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-30 Lanolin. Supplement. Eye Irritation.
23.
BTL. (October, 1975). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-40 Lanolin. Appendix 3. Eye Irritation.
24.
ICI AMERICA. (January, 1976). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-50 Lanolin. Appendix 6. Eye Irritation.
25.
FDRL. (December, 1974). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 1. Eye Irritation.
26.
LEBERCO LABORATORIES. (September, 1973). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 2. Eye Irritation.
27.
BTL. (June, 1970). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 3. Eye Irritation.
28.
HILLTOP RESEARCH. (June, 1971). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 5. Eye Irritation.
29.
ROSNER-HIXSON LABORATORIES. (February, 1965). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 4. Eye Irritation.
30.
BTL. (November, 1976). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-85 Lanolin. Appendix 5. Eye Irritation.
31.
ICI AMERICA. (April, 1976). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-20 Lanolin. Appendix 6. Primary Skin Irritation.
32.
BTL. (July, 1975). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-27 Lanolin. Appendix 5. Primary Skin Irritation.
33.
HUNTINGDON RESEARCH CENTER. (February, 1973). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-30 Lanolin. Supplement. Primary Skin Irritation.
34.
BTL. (October, 1975). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-40 Lanolin. Appendix 3. Primary Skin Irritation.
35.
FDRL. (December, 1974). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 1. Primary Skin Irritation.
36.
HILLTOP RESEARCH. (June, 1971). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 5. Primary Skin Irritation.
37.
LEBERCO LABORATORIES. (September, 1973). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 2. Primary Skin Irritation.
38.
ROSNER-HIXSON LABORATORIES. (February, 1965). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 4. Skin Irritation.
39.
CONSUMER PRODUCT TESTING. (November, 1976). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 1. Primary Skin Irritation.
40.
BTL. (November, 1976). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-85 Lanolin. Appendix 5. Primary Skin Irritation.
41.
FDRL. (December, 1974). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 1. Dermal Corrosion.
42.
CONSUMER PRODUCT TESTING. (November, 1976). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-40 Lanolin. Appendix 1. Dermal Corrosion.
43.
LEBERCO LABORATORIES. (September, 1973). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 2. Dermal Corrosion.
44.
ROSNER-HIXSON LABORATORIES. (February, 1965). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 4. Sensitivity.
45.
PRODUCT INVESTIGATIONS. (April, 1977). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-75 Lanolin. Appendix 1. Clinical Assessment.
46.
ICI AMERICA. (April, 1976). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-20 Lanolin. Appendix 6. Clinical Assessment.
47.
ICI AMERICA. (January, 1976). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-50 Lanolin. Appendix 6. Clinical Assessment.
48.
EMERY CHEMICAL CO. (September, 1979). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-40 and PEG-75 Lanolin. Appendix 6. Clinical Assessment.
49.
FOOD AND DRUG ADMINISTRATION (FDA). (August 31, 1976). Cosmetic product formulation data. Ingredients Used in Each Product Category. Washington, DC: Food and Drug Administration.
50.
ICI AMERICA. (January, 1976). Submission of data in support of safety of PEG-Lanolins. Prepared by CTFA Sub-Task Force. PEG-50 Lanolin. Appendix 6. Primary Skin Irritation.
